Cargando…

A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy

Currently, decision-making regarding biochemical recurrence (BCR) following prostatectomy relies solely on clinical parameters. We therefore attempted to develop an integrated prediction model based on a molecular signature and clinicopathological features, in order to forecast the risk for BCR and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Run, Bao, Xuanwen, Weischenfeldt, Joachim, Schaefer, Christian, Rogowski, Paul, Schmidt-Hegemann, Nina-Sophie, Unger, Kristian, Lauber, Kirsten, Wang, Xuanbin, Buchner, Alexander, Stief, Christian, Schlomm, Thorsten, Belka, Claus, Li, Minglun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017310/ https://www.ncbi.nlm.nih.gov/pubmed/31861273 http://dx.doi.org/10.3390/cancers12010001

Ejemplares similares

Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy
por: Schmidt-Hegemann, Nina-Sophie, et al.
Publicado: (2018)

Establishment and Validation of an Individualized Cell Cycle Process-Related Gene Signature to Predict Cancer-Specific Survival in Patients with Bladder Cancer
por: Shi, Run, et al.
Publicado: (2020)

Radiotherapy of oligometastatic prostate cancer: a systematic review
por: Rogowski, Paul, et al.
Publicado: (2021)

Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients
por: Shi, Run, et al.
Publicado: (2021)

Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy
por: Rogowski, Paul, et al.
Publicado: (2021)

Elective nodal radiotherapy with a gapless radiation field junction for oligorecurrent prostate cancer after previous radiotherapy
por: Li, Minglun, et al.
Publicado: (2022)

PSMA-positive nodal recurrence in prostate cancer: Salvage radiotherapy is superior to salvage lymph node dissection in retrospective analysis
por: Schmidt-Hegemann, Nina-Sophie, et al.
Publicado: (2020)

Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy
por: Schmidt-Hegemann, Nina-Sophie, et al.
Publicado: (2017)

Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer
por: Rogowski, Paul, et al.
Publicado: (2021)

DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score
por: Unger, Kristian, et al.
Publicado: (2023)

Tumor microenvironment characterization in head and neck squamous carcinoma reveals distinct genomic alterations and clinical outcomes
por: Shi, Run, et al.
Publicado: (2020)

Outcome After 68Ga-PSMA-11 versus Choline PET-Based Salvage Radiotherapy in Patients with Biochemical Recurrence of Prostate Cancer: A Matched-Pair Analysis
por: Schmidt Hegemann, Nina-Sophie, et al.
Publicado: (2020)

Occurrence of symptomatic lymphocele after open and robot-assisted radical prostatectomy
por: Magistro, Giuseppe, et al.
Publicado: (2021)

APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases
por: Shi, Run, et al.
Publicado: (2022)

Radiotherapy in oligometastatic prostate cancer—a pattern of care survey among members of the German Society for Radiation Oncology (DEGRO)
por: Rogowski, Paul, et al.
Publicado: (2022)

Patient-Reported and Oncological Outcomes of Salvage Therapies for PSMA-Positive Nodal Recurrent Prostate Cancer: Real-Life Experiences and Implications for Future Trial Design
por: Kretschmer, Alexander, et al.
Publicado: (2021)

Distribution of prostate nodes: a PET/CT-derived anatomic atlas of prostate cancer patients before and after surgical treatment
por: Hegemann, Nina-Sophie, et al.
Publicado: (2016)

Prospective comparison of one year follow-up outcomes for the open complete intrafascial retropubic versus interfascial nerve-sparing radical prostatectomy
por: Khoder, Wael Y, et al.
Publicado: (2014)

Health-Related Quality of Life following Cytoreductive Radical Prostatectomy in Patients with De-Novo Oligometastatic Prostate Cancer
por: Chaloupka, Michael, et al.
Publicado: (2021)

Perioperative blood loss in open retropubic radical prostatectomy - is it safe to get operated at an educational hospital?
por: Karl, A, et al.
Publicado: (2009)

Impact of a low FODMAP diet on the amount of rectal gas and rectal volume during radiotherapy in patients with prostate cancer – a prospective pilot study
por: Schaefer, Christian, et al.
Publicado: (2020)

Management of pelvic lymphoceles after radical prostatectomy: A multicentre community based study
por: Khoder, WY, et al.
Publicado: (2011)

Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy
por: Oehus, Ann-Kathrin, et al.
Publicado: (2020)

Robot-assisted radical prostatectomy significantly reduced biochemical recurrence compared to retro pubic radical prostatectomy
por: Fujimura, Tetsuya, et al.
Publicado: (2017)

MicroRNA expression profiles in human cancer cells after ionizing radiation
por: Niemoeller, Olivier M, et al.
Publicado: (2011)

The Metabolic Syndrome and Biochemical Recurrence following Radical Prostatectomy
por: Post, Jennifer M., et al.
Publicado: (2011)

Predictive factors for biochemical recurrence in radical prostatectomy patients
por: Turk, Hakan, et al.
Publicado: (2015)

Prediction of biochemical recurrence after laparoscopic radical prostatectomy
por: Bejrananda, Tanan, et al.
Publicado: (2023)

Hypofractionated radiotherapy for prostate cancer
por: Hegemann, Nina-Sophie, et al.
Publicado: (2014)

A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy
por: Haese, Alexander, et al.
Publicado: (2020)

Characterization of immune landscape in papillary thyroid cancer reveals distinct tumor immunogenicity and implications for immunotherapy
por: Sun, Jing, et al.
Publicado: (2021)

Combined Open Prostatectomy and Kidney Surgery: Feasibility and 12-Month Outcome
por: Rath, Lukas, et al.
Publicado: (2021)

Health-related quality of life after open and robot-assisted radical prostatectomy in low- and intermediate-risk prostate cancer patients: a propensity score-matched analysis
por: Kretschmer, Alexander, et al.
Publicado: (2020)

Cell cycle progression score as a predictive biomarker for overall survival in patients with adrenocortical carcinoma
por: Sun, Jing, et al.
Publicado: (2020)

Prognostic Factors for the Development of Biochemical Recurrence after Radical Prostatectomy
por: Kotb, Ahmed F., et al.
Publicado: (2011)

Salvage Radiotherapy after Radical Prostatectomy: Prediction of Biochemical Outcomes
por: Kwon, Ohseong, et al.
Publicado: (2014)

Biochemical recurrence after radical prostatectomy: what does it mean?
por: Tourinho-Barbosa, Rafael, et al.
Publicado: (2018)

Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy
por: Falagario, Ugo Giovanni, et al.
Publicado: (2023)

Correction to: Health-related quality of life after open and robot-assisted radical prostatectomy in low- and intermediate-risk prostate cancer patients: a propensity score-matched analysis
por: Kretschmer, Alexander, et al.
Publicado: (2021)

Robot-assisted radical prostatectomy has lower biochemical recurrence than laparoscopic radical prostatectomy: Systematic review and meta-analysis
por: Lee, Seon Heui, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b1227va2iqrisvic5k2ts40dvm